Dupont Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-7,498
| Closed | -$139K | – | 850 |
|
|
2022
Q4 | $139K | Sell |
7,498
-10,704
| -59% | -$199K | 0.01% | 872 |
|
|
2022
Q3 | $234K | Sell |
18,202
-28,557
| -61% | -$367K | 0.01% | 843 |
|
|
2022
Q2 | $328K | Hold |
46,759
| – | – | 0.02% | 843 |
|
|
2022
Q1 | $388K | Sell |
46,759
-4,136
| -8% | -$34.3K | 0.02% | 866 |
|
|
2021
Q4 | $345K | Sell |
50,895
-20,292
| -29% | -$138K | 0.01% | 931 |
|
|
2021
Q3 | $377K | Sell |
71,187
-10,062
| -12% | -$53.3K | 0.01% | 999 |
|
|
2021
Q2 | $467K | Hold |
81,249
| – | – | 0.01% | 1039 |
|
|
2021
Q1 | $375K | Sell |
81,249
-16,663
| -17% | -$76.9K | 0.01% | 1068 |
|
|
2020
Q4 | $327K | Sell |
97,912
-7,307
| -7% | -$24.4K | 0.01% | 1010 |
|
|
2020
Q3 | $313K | Buy |
+105,219
| New | +$313K | 0.01% | 954 |
|